openPR Logo
Press release

Etomidate Injection Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

02-08-2024 12:17 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Valuates Reports

Global Etomidate Injection Market
Etomidate injection, the indication is intravenous general anesthesia induction drug or anesthesia adjuvant.COVID-19 has erupted in the world, and these drugs are in short supply.
The global Etomidate Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-30Z7584/Global_Etomidate_Injection_Market_Insights_and_Forecast_to_2028
North American market for Etomidate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Etomidate Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Etomidate Injection include Pfizer, Athenex, AuroMedics, Zydus, American Regent, Hikma, Mylan, Par Sterile Products and Sagent, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Etomidate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Etomidate Injection.
The Etomidate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Etomidate Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Etomidate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-30Z7584/Global_Etomidate_Injection_Market_Insights_and_Forecast_to_2028
Key Segmentations
By Company
• Pfizer
• Athenex
• AuroMedics
• Zydus
• American Regent
• Hikma
• Mylan
• Par Sterile Products
• Sagent
• Jiangsu Hengrui Medicine
• Jiagnsu Nhwa Group
Segment by Type
• 20mg/10ml
• 40mg/20ml
Segment by Application
• Hospital
• Clinics
• Recovery Center

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-30Z7584/global-etomidate-injection

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Etomidate Injection Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports here

News-ID: 3377827 • Views:

More Releases from Valuates Reports

Composite Copper Foil Market Share Driven by Battery Innovation, Energy Storage Expansion, and Lightweight Conductive Material Demand | Valuates Reports
Composite Copper Foil Market Share Driven by Battery Innovation, Energy Storage …
Composite Copper Foil Market Size The global Composite Copper Foil market was valued at US$ 91.02 million in 2025 and is anticipated to reach US$ 6661 million by 2032, at a CAGR of 85.9% from 2026 to 2032 View sample report https://reports.valuates.com/request/sample/QYRE-Auto-2Q13831/Global_Composite_Copper_Foil_Market_Research_Report_2023 The Composite Copper Foil Market is gaining strategic importance as battery manufacturers and electronics industries increasingly seek advanced conductive materials that improve energy density, reduce weight, and enhance the performance of next-generation
Ethylene Tetrafluoroethylene (ETFE) Coatings Market Share Driven by High-Performance Material Demand, Industrial Protection Requirements, and Advanced Engineering Applications | Valuates Reports
Ethylene Tetrafluoroethylene (ETFE) Coatings Market Share Driven by High-Perform …
Ethylene Tetrafluoroethylene (ETFE) Coatings Market Size Coatings was valued at US$ 45.2 million in the year 2024 and is projected to reach a revised size of US$ 49.4 million by 2031, growing at a CAGR of 1.3% during the forecast period. View sample report https://reports.valuates.com/market-reports/QYRE-Auto-13W4384/global-ethylene-tetrafluoroethylene-etfe-coatings The Ethylene Tetrafluoroethylene (ETFE) Coatings Market continues to expand as industries increasingly adopt high-performance fluoropolymer coatings for applications requiring exceptional chemical resistance, durability, electrical insulation, and protection against harsh
GRP & GRE Pipe Market Share Driven by Oil and Gas Infrastructure Expansion, Corrosion Resistance Requirements, and Sustainable Pipeline Solutions | Valuates Reports
GRP & GRE Pipe Market Share Driven by Oil and Gas Infrastructure Expansion, Corr …
GRP & GRE Pipe Market Size The global GRP & GRE Pipe market was valued at US$ 3396 million in 2025 and is anticipated to reach US$ 4914 million by 2032, at a CAGR of 5.5% from 2026 to 2032. View sample report https://reports.valuates.com/request/sample/QYRE-Auto-074/Global_GRP_GRE_Pipe_Market_Size_Manufacturers_Supply_Chain_Sales_Channel_and_Clients_2021_2027 The GRP & GRE Pipe Market continues to expand as industries increasingly adopt fiber-reinforced composite piping systems to replace conventional metal pipelines in applications requiring corrosion resistance, durability, and reduced
Dicalcium Phosphate Market Share Driven by Animal Nutrition Demand, Agricultural Productivity, and Food Industry Applications | Valuates Reports
Dicalcium Phosphate Market Share Driven by Animal Nutrition Demand, Agricultural …
Dicalcium Phosphate Market Size The global Dicalcium Phosphate revenue was US$ 1517.5 million in 2022 and is forecast to a readjusted size of US$ 1464.6 million by 2029 with a CAGR of -0.5% during the forecast period (2023-2029). View sample report https://reports.valuates.com/request/sample/QYRE-Auto-18O15932/Global_and_India_Dicalcium_Phosphate_Market_Report_Forecast_2023_2029 The Dicalcium Phosphate Market continues to expand as demand increases across animal nutrition, agriculture, food processing, and industrial applications where phosphate-based compounds play an important role in supporting productivity and product quality.

All 5 Releases


More Releases for Etomidate

Etomidate Market Share, Size, Growth, Forecast, and Analysis | Valuates Reports
Etomidate Market Etomidate is a hypnotic intravenous anesthetic, which is a derivative of imidazoles. It is safe and one of the commonly used drugs for anesthesia induction. Etomidate has been used in clinical practice for 30 years.Etomidate is a non-barbiturate intravenous tranquilizer, which is the hydroxylated salt of imidazole. Its structural formula is as shown in the following figure. Its molecular formula is C14H16N2O2, and its molecular weight is 244.29.Etomidate is
Etomidate Market is Dazzling Worldwide and Forecast to 2030
Etomidate Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 24.18% from 2024 to 2030. The etomidate market is witnessing steady growth, driven by factors such as increasing surgical procedures, rising demand for safer anesthetic agents, and expanding applications in critical care settings. Etomidate, a non-barbiturate hypnotic agent, produces rapid and smooth induction of anesthesia with minimal
Etomidate Injection Market Disclosing Latest Advancement 2023 to 2028 Russo-Ukra …
Crafting a beneficial marketing strategy is easy with this unique Etomidate Injection market analysis. It helps market players in better understanding of target market of the company. By knowing target market, launchings of better products and expanding the business becomes easy. This research analysis provides pricing structure, new advancements in the market and best customer experience. It further provides quick insights into driving and hindering factors of market growth along
Global Etomidate Injections Market Trends, Business Overview, Industry Growth an …
The global etomidate injections market is anticipated to grow at a considerable CAGR 6% during the forecast period (2022-2028). Etomidate injections are hypnotic drugs used as anesthesia in several medical procedures, including tracheal intubation, cardioversion, and electroconvulsive therapy. The major factor attributing to the growth of the global etomidate injections market includes the rising application of etomidate injection in cardioversion procedures due to increasing cases of atrial fibrillation. According to
Etomidate Market Trends, Business Overview, Industry Growth and Forecast to 2027
The Global Etomidate Market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Etomidate is a hypnotic intravenous anesthetic, a derivative of imidazole. It is one of the safe and commonly used drugs for inducing anesthesia. Etomidate has been used in clinical practice for 30 years, etomidate is an oxalate flame
Etomidate Market: Growth and Development Strategies by 2026
The report offers thorough analysis of the global etomidate market by meticulously studying different aspects of the market including market dynamics, major segments, growth opportunities, regional market conditions, and leading players operating in the market. This research report sheds a light on the current market scenario and upcoming trends & developments predicted to contribute for the global market growth during the forecast period. In addition, key market drivers and opportunities boosting